Aidan Synnott

Aidan Synnott

Chief Executive Officer at ONCODESIGN
48 year
Commercial Services
Health Technology
Finance

Profile

Aidan John Synnott is Co-Chief Executive Officer at CRL Group France SAS since 2019.
He is Chief Executive Officer at Oncodesign SA starting in 2025.
He serves as Chairman at Charles River Laboratories France Safety Assessment SAS since 2018 and at Charles River Laboratories Evreux SAS. Formerly, Mr. Synnott was Director at KWS Biotest Ltd.

Aidan Synnott active positions

CompaniesPositionStart
ONCODESIGN Chief Executive Officer 2025-04-10
Chairman 2018-07-04
Chairman -
Chief Executive Officer 2019-05-29

Former positions of Aidan Synnott

CompaniesPositionEnd
Director/Board Member -
See the detail of Aidan Synnott's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

15

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance